The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...

Starting this year, Sanofi will record sales of the Covid-19 shot vaccine Nuvaxovid, paying Novavax royalties on those sales. The deal is more than a financial lifeline.

Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...

Novavax says it will earn royalties in the "high teens to low twenties" on net product sales of Nuvaxovid, and as we can see in the table below, if Sanofi initiates a pivotal program for a COVID ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Per Novavax, these responses were similar to those seen with its own approved COVID-19 vaccine, Nuvaxovid, and Sanofi ’s SNY influenza vaccine, Fluzone HD.

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

Novavax (NasdaqGS:NVAX) recently reported initial results from its Phase 3 trial for its COVID-19-Influenza Combination and seasonal influenza vaccines, which showed immune responses comparable to ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.